Loading company…
Phaeno Thera develops anti-infective drugs, including candidates for viral infections.
Founded in 2018 and based in Hangzhou, China, Phaeno Thera develops anti-infective drugs and has an office and biosafety secondary laboratory in Shanghai. Its programs include HN0141 for human cytomegalovirus and HN0037 for herpes simplex virus.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in